Related references
Note: Only part of the references are listed.Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle
Maja Z. Salva et al.
MOLECULAR THERAPY (2007)
Sustained whole-body functional rescue in congestive heart failure and muscular dystrophy hamsters by systemic gene transfer
T Zhu et al.
CIRCULATION (2005)
Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery
S Abmayr et al.
MOLECULAR THERAPY (2005)
Therapeutic levels of factor IX expression using a muscle-specific promoter and adeno-associated virus serotype 1 vector
YL Liu et al.
HUMAN GENE THERAPY (2004)
Expression of dystrophin driven by the 1.35-kb MCK promoter ameliorates muscular dystrophy in fast, but not in slow muscles of transgenic Mdx mice
P Dunant et al.
MOLECULAR THERAPY (2003)
Transgenic and tissue culture analyses of the muscle creatine kinase enhancer Trex control element in skeletal and cardiac muscle indicate differences in gene expression between muscle types
QGV Nguyen et al.
TRANSGENIC RESEARCH (2003)
Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product
K Yuasa et al.
GENE THERAPY (2002)
A novel gene expression control system and its use in stable, high-titer 293 cell-based adeno-associated virus packaging cell lines
CP Qiao et al.
JOURNAL OF VIROLOGY (2002)
Viral vectors for gene transfer of micro-, mini-, or full-length dystrophin
JM Scott et al.
NEUROMUSCULAR DISORDERS (2002)
Gene therapy of muscular dystrophy
JS Chamberlain
HUMAN MOLECULAR GENETICS (2002)
Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice
J Watchko et al.
HUMAN GENE THERAPY (2002)
Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene
M Sakamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
The short MCK1350 promoter/enhancer allows for sufficient dystrophin expression in skeletal muscles of mdx mice
N Larochelle et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes
CP Qiao et al.
JOURNAL OF VIROLOGY (2002)
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
SQ Harper et al.
NATURE MEDICINE (2002)
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters
RD Weeratna et al.
GENE THERAPY (2001)
Immune evasion by muscle-specific gene expression in dystrophic muscle
D Hartigan-O'Connor et al.
MOLECULAR THERAPY (2001)
Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model
B Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors
MA Hauser et al.
MOLECULAR THERAPY (2000)
Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer
L Cordier et al.
MOLECULAR THERAPY (2000)
CD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: Role of immature dendritic cells
Y Zhang et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
